MTCAX
Price
$70.15
Change
+$0.52 (+0.75%)
Updated
Jul 31 closing price
Net Assets
2.29B
SCMIX
Price
$280.69
Change
+$1.20 (+0.43%)
Updated
Jul 31 closing price
Net Assets
27.54B
Interact to see
Advertisement

MTCAX vs SCMIX

MTCAX vs SCMIX Comparison Chart in %
View a ticker or compare two or three
VS
MTCAX vs. SCMIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTCAX is a Buy and SCMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SCMIX has more cash in the bank: 27.5B vs. MTCAX (2.3B). MTCAX (0.00) and SCMIX (0.00) have matching dividends . MTCAX was incepted earlier than SCMIX: MTCAX (30 years) vs SCMIX (25 years). MTCAX (1.12) is less costly to investors than SCMIX (0.87). MTCAX is a more actively managed with annual turnover of: 50.00 vs. SCMIX (33.00). SCMIX has a lower initial minimum investment than MTCAX: SCMIX (0) vs MTCAX (1000). SCMIX annual gain was more profitable for investors over the last year : 68.87 vs. MTCAX (4.84). SCMIX return over 5 years is better than : 93.95 vs. MTCAX (-4.25).
MTCAXSCMIXMTCAX / SCMIX
Total Expense Ratio1.110.87128%
Annual Report Gross Expense Ratio1.120.87129%
Fund Existence30 years25 years-
Gain YTD13.23646.48328%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.3B27.5B8%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.8468.877%
Returns for 3 years34.52115.9330%
Returns for 5 years-4.2593.95-5%
Returns for 10 years154.17348.6744%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AAAA30.030.15
+0.49%
Amplius Aggressive Asset Allocation ETF
DON57.52-0.05
-0.09%
WisdomTree US MidCap Dividend ETF
AVSD81.18-0.50
-0.62%
Avantis Responsible International Eq ETF
LIAU252.82-3.16
-1.23%
LifeX 2060 Infl-Prt Longevity Income ETF
GNOM54.17-1.22
-2.21%
Global X Genomics & Biotechnology ETF